Consumer Reports on the dangers of opioids and acetaminophen

Consumer Reports recently released “Special report: The dangers of painkillers” in an effort to shed light on misconceptions surrounding the use of opioids and acetaminophen in the treatment of pain.  For their full take on dangerous doses, extended-release medications, the potential for addiction, and more, click the link below.

Editorial: End the pill-pusher’s paradise. Enact a prescription drug database

Missouri remains the only state in the nation without a prescription drug monitoring program, thus making the state a ripe target for pill mill operators and those with addiction to painkillers.  According to Express Scripts, a pharmacy benefit manager in St. Louis, visitors to Missouri have prescriptions filled in the state than Missourians have their […]

Migraine Buddy helps patients and doctors work together for better treatment

Excerpt: Healint has released a new mobile platform that it hopes will help patients and doctors do a better job of collaborating on migraine care. Called Migraine Buddy, it consists of an app that sufferers can use to keep a comprehensive record of their symptoms, and dashboard with data that doctors can reference during checkups. […]

House passes bill aimed at reducing prescription drug abuse

The House recently passed legislation that would amend the Controlled Substances Act to modify the definition of “imminent danger to the public health or safety” so that it applies to drugs that pose present or foreseeable health risks.  The bill also has a corresponding provision that would allow prescription drug companies to submit a “corrective action […]

New public television special facilitates national pain management dialogue

Excerpt: A new public television special titled “Learning about Pain Management” will begin airing nationally this August on the Public Television Network as part of the Healthy Body, Healthy Mind (HBHM) series. HBHM, a production of the Information Television Network (ITV), is being supported in part by Mallinckrodt Pharmaceuticals without content control. The 30-minute program […]